The strategic use of intellectual and industrial property laws to maintain and extend a dominant position in the pharmaceutical industry
Bibliographic record
Abstract
It is assumed at the outset of this thesis that there is a public interest in the purchase of prescribed drugs at the lowest aggregate price consistent with the maintenace of reseach and development in the pharmaceutical field. The thesis investigates the operation of intellectual property law in this area and its effect on prices, investment, research and the availability of new drugs. The principal focus is on the United Kingdom but the conclusions reached may be validly applied to other jurisdictions. Each chapter is devoted to a specific branch of the law with a view to demonstrating how its exploitation by pharmaceutical firms has operated in the detriment of the public by virtually eliminating competition and thereby increasing prices. The unique nature of the pharmaceutical industry renders the desirability of exclusive rights in this area highly questionable and the abolition or curtailment of all forms of protection for pharmaceutical products is advocated.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.022 | 0.026 |
| Meta-epidemiology (narrow) | 0.000 | 0.001 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.002 | 0.002 |
| Science and technology studies | 0.006 | 0.062 |
| Scholarly communication | 0.015 | 0.010 |
| Open science | 0.002 | 0.006 |
| Research integrity | 0.006 | 0.008 |
| Insufficient payload (model declined to judge) | 0.002 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".